Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $20.57 Analyst target: $30.53 Upside: 48.42%
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company is headquartered in San Diego, California.
See the full interactive analysis & chart →Informational only — not investment advice.